Sanodyne Therapeutics, Inc. is a biopharmaceutical company focused on the research and development of novel therapeutics for neurology and pain-related conditions. The company advances drug candidates through preclinical and early clinical stages with the aim of addressing unmet medical needs in nerve-related disorders.
Sanodyne’s activities include translational research, clinical development, and collaboration with external partners through licensing and development agreements. Its work centers on building a pipeline of innovative therapies with the potential to improve outcomes for patients with neuropathic and other pain syndromes.
